Daniel G. Welch - 24 May 2024 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
29 May 2024, 16:38:34 UTC
Prior SEC filing
17 May 2024
Next SEC filing
20 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ron A. Metzger, Attorney-in-Fact

Key filing fact

Daniel G. Welch filed Form 4 for Nuvation Bio Inc. (NUVB) on 29 May 2024.

Key facts

  • This page summarizes Daniel G. Welch's Form 4 filing for Nuvation Bio Inc. (NUVB).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 29 May 2024, 16:38.

Change

  • Previous filing in this sequence was filed on 17 May 2024.
  • Current net transaction value: +$1,111,633.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUVB transaction

Class A Common Stock

Options Exercise

Transaction value
$510,173
Shares
+293,203
Change %
Price
$1.74
Shares after
293,203
Date
24 May 2024
Ownership
Direct
NUVB transaction

Class A Common Stock

Options Exercise

Transaction value
$601,460
Shares
+366,744
Change %
+125%
Price
$1.64
Shares after
659,947
Date
24 May 2024
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NUVB transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-293,203
Change %
-94%
Price
$0.000000
Shares after
19,547
Date
24 May 2024
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
293,203
Exercise price
$1.74
Footnotes
F1
NUVB transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-366,744
Change %
-100%
Price
$0.000000*
Shares after
0
Date
24 May 2024
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
366,744
Exercise price
$1.64
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Option vests in 48 equal monthly installments from July 22, 2020.

Footnote F2

Option is fully vested and exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .